Evaluating new therapies for psoriasis.
Morrow
Thomas
T
Matria Healthcare, Atlanta, USA.
D001685:Biological Factors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy; D008991:Monitoring, Physiologic; D011565:Psoriasis / Q000276:immunology / Q000628:therapy*; D014481:United States
D001685:Biological Factors